GMP Compliance for Drug and Biotech Products
Clarion Quality supports pharmaceutical companies in the UK to meet rigorous Good Manufacturing Practice (GMP) standards for active pharmaceutical ingredients (APIs), finished medicines, and emerging biotech therapies.
API and Drug Product GMP Compliance
We help ensure all materials and processes meet UK and EU GMP requirements, covering every aspect from raw material sourcing to product release.
Biotech Product Support
Advisory services tailored to emerging biotech therapies, ensuring regulatory standards are met for advanced therapy medicinal products (ATMPs) and novel biologics.
Supply Chain Integrity
Guidance on supplier qualification and GMP supplier audits, ensuring your value chain is secure and compliant.
Inspection Readiness
Support in preparing for MHRA inspections, gap analyses, and continuous improvement, minimising risk and maximising compliance.
Ongoing Compliance Monitoring
Continuing support to maintain compliance in line with rapidly evolving pharmaceutical regulations.
Quality Systems Implementation for APIs, Medicines, and New Therapies
Robust quality systems form the backbone of pharmaceutical excellence. At Clarion Quality, our approach combines international regulatory alignment with practical, sector-specific expertise.
Pharmaceutical Quality Systems (PQS)
Design, implementation, and review of PQS structures that meet the latest GMP and ISO 9001 standards required by UK authorities and international bodies.
Documentation Control:
Establishment of clear, structured systems for document creation, management, and retention, supporting strong audit trails and accountability.
Process Validation
Ensuring quality is built into processes for both conventional and new therapies, from scale-up development to commercial manufacture.
Digital Transformation
Supporting transitions to electronic quality management systems and digital record keeping, aligned with data integrity requirements.
Inspection Preparation
Ongoing system review and mock inspections to ensure readiness for regulatory, customer, or internal audits.
Support for Clinical Trials and Investigational Products
Clinical development demands high standards of quality and compliance. Clarion Quality guides UK pharmaceutical companies through GMP and good clinical practice (GCP) for investigational medicinal products (IMPs).
- GMP for Clinical Manufacturing: Ensuring manufacturing of IMPs meets GMP requirements, securing patient safety and data integrity during clinical trials.
- GxP Interface Support: Bridging GMP and GCP where these disciplines meet, especially important in early-phase and pilot-scale manufacture.
- IMP Release and Labelling: Guidance on QP release, packaging, labelling, and distribution in line with national and international requirements.
- Risk Assessment: Providing risk-based approaches to GMP for investigational products, helping companies adapt to regulatory expectations.
- Trial Site Compliance: Support for investigator sites and contract research organisations to maintain compliance with GCP and GMP expectations.
Pharmaceutical Industry Compliance Audits and Training
A quality culture is the foundation of sustainable compliance. Clarion Quality brings thorough auditing, insightful analysis, and effective training to pharmaceutical businesses in the UK.
- GMP Audits and Gap Analysis: In-depth audits of processes, facilities, and quality systems to identify strengths and vulnerabilities within your GMP arrangements.
- Supplier and Third-Party Audits: Evaluation of your supply chain partners, with clear reporting and recommendations to drive improvements and ensure reliability.
- Regulatory Submission Support: Assistance in preparing documentation and aligning practices for seamless regulatory interactions and submissions.
- Customised Staff Training: Bespoke training packages to upskill staff in GMP fundamentals, regulatory changes, and new technologies, supporting ongoing professional development.
- Embedding a Quality Culture: Workshops and guidance sessions designed to empower your team, fostering accountability and compliance-led decision-making.
Frequently Asked Questions
What is GMP and why is it important in pharmaceutical manufacturing?
GMP (Good Manufacturing Practice) is a set of guidelines ensuring pharmaceutical products are consistently produced and controlled to quality standards. It is essential to protect patient safety, ensure product efficacy, and comply with regulatory requirements.
What is a Pharmaceutical Quality System (PQS)?
A PQS is a comprehensive quality management framework aligned with GMP and ISO 9001 that ensures all processes, documentation, and controls within pharmaceutical manufacturing meet strict regulatory standards.
How can pharmaceutical companies prepare for regulatory inspections?
Companies can prepare by implementing robust quality management systems, conducting regular GMP audits and gap analyses, ensuring thorough documentation, and providing ongoing staff GMP training to maintain inspection readiness.
What are GMP Annex 1 and Annex 13 requirements?
Annex 1 covers regulations for sterile pharmaceutical manufacture, while Annex 13 outlines requirements for GMP compliant production and management of investigational medicinal products used in clinical trials.
How do GMP, GLP, and GCP differ?
GMP governs manufacturing quality, GLP covers laboratory testing standards, and GCP applies to clinical trials, ensuring every stage of drug development meets the specific quality guidelines relevant to the stage.
What compliance requirements apply to investigational medicinal products?
IMPs must meet GMP and GCP standards, covering manufacturing, labelling, documentation, release processes, and risk assessment to protect trial participant safety and ensure data integrity.
Get in Touch
Ready to strengthen your pharmaceutical quality systems or arrange GMP consultancy and training? Contact us today.
Services
Clarion Quality GXP UK Limited - Company number 12675976 - Registered in England & Wales